CRT 2025
Power Break Symposium
David E. Kandzari, MD, FACC, FSCAI
Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure(s): Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Ablative Solutions, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); DeepQure: Consulting Fees (e.g., advisory boards) (Ongoing); GoldenLeaf Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Supira Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)